Dr.Reddy's Laboratories Ltd (REDY.BO)

REDY.BO on Bombay Stock Exchange

3 Sep 2015
Change (% chg)

-- (--)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for REDY.BO


Dr. Reddy's Laboratories Limited is an integrated global pharmaceutical company that is engaged in providing medicines. The Company operates in three segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Proprietary Products. Global Generics segment consists of its business of manufacturing and... (more)


Beta: 0.30
Market Cap(Mil.): Rs716,497.38
Shares Outstanding(Mil.): 170.59
Dividend: 20.00
Yield (%): 0.48


  REDY.BO Industry Sector
P/E (TTM): 204.20 35.45 35.59
EPS (TTM): 20.57 -- --
ROI: -- 15.51 14.96
ROE: -- 16.08 15.84
Search Stocks

BUZZ-Indian drugmakers up; CLSA says transition to complex drugs to drive re-rating

** Indian drugmakers' transition to making complex generics from simple should drive significant re-rating - CLSA

06 Aug 2015

BUZZ-India's Dr.Reddy's rises on generic drug launch

** Dr.Reddy's Laboratories rises as much as 1.9 pct to record high

14 Jul 2015

BUZZ-Australia's Alchemia hits record low

** Drug developer Alchemia Ltd slumps as much as 57.8 pct to a record low of A$0.035

29 May 2015

BUZZ-India's Dr.Reddy's up on hopes of US FDA resolution of Srikakulam plant

** The generic drug maker remains confident of a faster resolution of US FDA observations at the Srikakulam plant - CLSA

31 Mar 2015

BUZZ-India's Dr.Reddy's rises on agreement to market new drug

** Shares of Indian pharmaceutical company Dr.Reddy's Laboratories Ltd gain 1.1 pct

24 Mar 2015

BUZZ-Investors take tactical refuge in Indian pharma ahead of Fed

** Pharmaceutical stocks, traditionally seen as defensives, gain on churning ahead of the U.S. Federal Reserve policy meeting outcome on Wednesday

17 Mar 2015

Dr.Reddy's in talks to buy UCB India business for $135 mln - source

MUMBAI, March 10 - Indian drugmaker Dr.Reddy's Laboratories Ltd is in talks to acquire the Indian operations of Belgian pharmaceutical company UCB SA for about $135 million, said a person with direct knowledge of the matter.

10 Mar 2015

Earnings vs. Estimates

Search Stocks